Skip to main content
OpenTrials
Completed

NCT Number: NCT03483233

Neural Bases of the Check Process

Effective exploration of the environment, check for information to improve one's own performance, are fundamental abilities of human cognition. These abilities are dependent on the process of cognitive control.

However, they are clearly impaired and uncontrollable in certain behavioral disorders such as obsessive-compulsive disorder (OCD). Compulsive checks of these patients, spontaneously associated with a feeling of intense uncertainty, suggest disturbances of evaluative and metacognitive functions. However, no biological observations have yet been able to feed these hypotheses.

The evaluation of decisions and actions involves the middle cingulate cortex (MCC) (which belongs to a cortico-subcortical network structurally and functionally altered in OCD patients). Cingulotomy has long been used as a therapy in severe OCD, with However, the precise part of the cingulate cortex that contributes to check (and its pathological forms) remains to be discovered.

The purpose of this research campaign is to determine, through functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) in healthy human subjects:

1. the location and role of the MCC region involved in normal check decision processes, 2. determine the identity of the entire network involved

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Inserm U1208

Bron, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults age range 20-45 years
  • being able to provide a written consent form
  • having a social insurance
  • have a normal vision (with or without corrections)
  • Right-handed

Exclusion criteria

  • Subjects with MRI contraindications (e.g. pacemaker, claustrophobia, metal in the body, etc…).
  • Pregnant subjects
  • Subjects with neurological history
  • Subjects must be willing to be advise in case of discovery of brain abnormality.

Treatment and study plan

fMRI and EEG study

Other

fMRI and EEG study

Primary outcomes

  1. Measuring changes in brain activity in regions of interest when performing cognitive tasks.

    Time frame: through study completion, an average of 3 years

    Behavior: Measurement of reaction times of correct answer during cognitive task.

    fMRI and EEG: Brain activity signal,

  2. Measuring changes in brain activity in regions of interest when performing cognitive tasks.

    Time frame: through study completion, an average of 3 years

    Behavior: Measurement of % of correct answer during cognitive task.

  3. Measuring changes in brain activity in regions of interest when performing cognitive tasks.

    Time frame: through study completion, an average of 3 years

    • Measurement of the amplitude of the BOLD signal change in MRI according to the different cognitive tasks in the different regions of interest. Measurement of resting GABA and Glutamate concentrations in the different regions of interest.

    Measurement of the amplitude of the change of the electrical signal in EEG according to the different cognitive tasks in the different regions of interest.

Secondary outcomes

  1. Calculation of the correlations in the regions of interest of the individual values of the Blood Oxygen Level Dependent (BOLD) signal with the data of the concentration of Acide γ-aminobutyrique (GABA)

    Time frame: through study completion, an average of 3 years

    calculate with the bold signal (spectroscopy)

  2. Calculation of the correlations in the regions of interest of the individual values of the Blood Oxygen Level Dependent (BOLD) signal with the data of the amplitude of the electrical signal (EEG)

    Time frame: through study completion, an average of 3 years

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Acronym: Check

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Mar 30, 2018
Registry last updated
Dec 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.